PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,251,000 | -24.3% | 1,118,652 | +1.3% | 0.00% | 0.0% |
| Q4 2019 | $5,619,000 | -0.8% | 1,103,905 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $5,663,000 | -12.7% | 1,120,441 | +6.6% | 0.00% | -50.0% |
| Q2 2019 | $6,486,000 | +29.9% | 1,051,257 | -2.3% | 0.00% | +100.0% |
| Q1 2019 | $4,994,000 | +11.6% | 1,076,341 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $4,476,000 | -34.0% | 1,066,046 | -1.4% | 0.00% | -50.0% |
| Q3 2018 | $6,779,000 | -9.8% | 1,081,103 | +15.6% | 0.00% | 0.0% |
| Q2 2018 | $7,516,000 | +15.1% | 934,820 | +6.8% | 0.00% | 0.0% |
| Q1 2018 | $6,529,000 | +25.3% | 875,262 | -0.1% | 0.00% | +100.0% |
| Q4 2017 | $5,211,000 | -20.1% | 875,841 | -1.2% | 0.00% | -50.0% |
| Q3 2017 | $6,525,000 | +7.3% | 886,616 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $6,081,000 | -25.2% | 895,458 | +3.9% | 0.00% | 0.0% |
| Q1 2017 | $8,135,000 | +14.4% | 861,684 | +4.7% | 0.00% | 0.0% |
| Q4 2016 | $7,110,000 | +40.5% | 822,911 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $5,060,000 | +48.2% | 799,251 | -1.2% | 0.00% | +100.0% |
| Q2 2016 | $3,414,000 | -4.1% | 808,834 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $3,560,000 | -26.3% | 816,699 | +3.6% | 0.00% | -50.0% |
| Q4 2015 | $4,832,000 | +8.8% | 788,259 | +1.5% | 0.00% | +100.0% |
| Q3 2015 | $4,442,000 | -18.2% | 776,767 | +6.7% | 0.00% | -50.0% |
| Q2 2015 | $5,429,000 | +24.1% | 727,780 | -0.5% | 0.00% | +100.0% |
| Q1 2015 | $4,376,000 | -19.4% | 731,730 | +1.9% | 0.00% | -50.0% |
| Q4 2014 | $5,431,000 | +40.7% | 718,405 | -3.4% | 0.00% | +100.0% |
| Q3 2014 | $3,859,000 | +16.4% | 743,629 | -3.3% | 0.00% | 0.0% |
| Q2 2014 | $3,316,000 | +2.8% | 769,300 | -2.5% | 0.00% | 0.0% |
| Q1 2014 | $3,227,000 | -29.3% | 788,855 | -7.9% | 0.00% | 0.0% |
| Q4 2013 | $4,565,000 | +13.0% | 856,489 | +6.4% | 0.00% | 0.0% |
| Q3 2013 | $4,040,000 | +32.5% | 804,783 | +17.8% | 0.00% | 0.0% |
| Q2 2013 | $3,049,000 | – | 683,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|